For 30 advance/early chapters : p atreon.com/AutumnXd
The news of Prism Sciences' counter-launch reached Helios headquarters within the hour.
Michael Reeve was on a call with one of the firm's senior board members when his executive assistant entered the office. Reeve gestured for the assistant to wait, the phone still pressed to his ear.
"Funding round timing? We're targeting January tenth," Reeve was saying. "Ten days after the Angel launch. We want the brand fully in market before the Series E announcement, so the press cycle has time to absorb the product narrative."
A pause as he listened.
"Are you considering increasing your participation? You'd be welcome. We've worked together for years, this won't be a problem at all."
The conversation continued for another minute, then Reeve set the phone down.
The assistant approached the desk and placed a printed news article in front of him.
"Boss. Prism Sciences just publicly counter-positioned. They've announced a launch event on January 1st. Same day as ours."
Reeve's first reaction was confusion.
"They're launching what, exactly?"
"A neural prosthetic. Their Mercer-branded product line. The official statement went up forty minutes ago."
Reeve picked up the printed page. Read it twice.
"Are they kidding? Do they think they're the Titanic? Volunteering to ram an iceberg?"
He removed his reading glasses, rubbed his eyes, and stared at the page again.
"Are these people reckless or do they actually have something?"
He turned the glasses idly between his fingers. The strategic question was real. Prism Sciences was a sub-million-dollar operation by any conventional metric. Helios had spent more on Angel's marketing budget than Prism Sciences had spent on its entire R&D effort. A direct collision on launch day looked, on paper, suicidal.
Unless Prism Sciences knew something that Reeve didn't.
He pivoted to the operational question. "What's the engagement profile on this story?"
The marketing question mattered more than the strategic one. Angel's launch wasn't really about selling prosthetics. It was about generating attention, which would translate into valuation uplift at the next funding round. Each engaged viewer was, in Reeve's mental model, worth roughly a dollar of investor confidence. Hundreds of millions of viewers translated to a meaningful adjustment to the company's pre-money valuation.
"It's already past ten million views across the major platforms. Mercer's audience trips into the conversation automatically because of the cross-mentions. He has standing readership in every market we care about."
"Is there any way to suppress this? Buy the major outlets, get the story killed in the news cycle?"
Reeve was not interested in sharing his marketing budget with Prism Sciences. He'd built the engagement around Angel using Ryan Mercer's visibility as cheap raw material, sure, but he'd done the work of converting that visibility into a controllable narrative. That conversion had cost Helios close to ten million dollars in coordinated PR spend. He'd watched a portion of that money disappear into troll farms that abruptly stopped responding to communications. Prism Sciences was now trying to consume the rest of his investment for free.
The assistant shrugged. "Mercer doesn't operate his own international accounts. All of his international visibility is from fan reposts. There's no central account we can demonetize, no commercial relationship we can disrupt. The only way to suppress the story would be to coordinate with state-level censorship, and that's not something we want to be associated with publicly. The optics would be terrible if it leaked."
Reeve nodded. He'd reached the same conclusion before the assistant finished speaking.
He lit a cigar, leaned back, and considered.
"If we can't suppress it, we frame it. Spin them as reckless amateurs picking a fight they can't win. Position Helios as the established player and Prism as the upstart making a publicity stunt. Get the analyst class to run the comparison stories on our terms."
The assistant nodded. He'd worked with Reeve long enough to translate the brief into specific actions. Coordinate with the same PR firms they'd used for the troll campaign, brief major business outlets, line up friendly analysts for op-ed placements, prep television talking heads with the desired narrative. The frame would be: Helios is a billion-dollar company with decades of accumulated R&D. Prism Sciences is a startup founded by a teenager. The launch collision was a marketing stunt by an underprepared challenger trying to ride Helios's coattails.
"I'll have the campaign live within twenty-four hours."
"Make sure the international reach is solid. I want this to be the dominant frame in every major market."
The assistant left the office.
Reeve smoked his cigar in silence for a moment. Then he remembered something Whitfield had told him during their last call: Mercer's prosthetic uses a different technology architecture. Non-invasive cortical signal acquisition. No surgery required.
Reeve had filed that information under "scientist's anxieties" and not given it serious weight. But now, with Prism Sciences openly volunteering for a head-to-head launch, the technical question was rising back to the top of his mind.
Was the technology the reason for the confidence?
He spent thirty minutes searching for any public information about Prism Sciences' technical approach. Their official site was minimalist. Their PR had been deliberately uninformative. Mercer's social media had teased nothing about the underlying technology. Every video showed the prosthetic in action without explaining how the neural acquisition worked.
The lack of information was itself information. Prism Sciences was deliberately holding back the technical details. They wanted the contrast to be a surprise on launch day.
Reeve put the cigar down. The unease in his stomach was small but persistent. Like a smoke alarm beeping in another room. Easy to ignore, but not easy to forget.
-----
The next day, the counter-narrative campaign went live.
Helios's marketing partners executed across every major channel. Domestic TV news. Late-night opinion shows. Tech podcasts. Print media op-eds. Online business commentary. The talking points were aligned across all venues:
"Established player Helios faces unprepared challenger."
"Prism Sciences' counter-launch viewed as risky publicity move by industry analysts."
"Will Prism Sciences embarrass itself on January 1st?"
"Helios's billion-dollar Angel product vs. teenage startup: the gap may be larger than fans realize."
The campaign's reach was significant. Within thirty-six hours, the framing had penetrated all major demographics across the country. Familiar pundits delivered the talking points with practiced confidence. Bloggers paraphrased the same arguments in slightly different phrasing.
Then the international expansion phase kicked in. The domestic coverage was clipped, subtitled, and redistributed across foreign markets. The framing traveled with it. International commentators picked up the narrative and added their own twists, with some particularly enterprising analysts framing the launch collision as a proxy battle between two technological ecosystems.
These international takes then re-imported back into the domestic conversation. A second wave of coverage discussed how foreign media was discussing the launch. The recursion generated additional engagement.
Within seventy-two hours, the launch collision had become the dominant story in the global business news cycle. Op-eds. Analysis pieces. Stock-market commentary speculating on the implications for Helios's pending Series E.
The internet's commenters, predictably, joined the war on both sides. Some praised Helios's "establishment credibility." Others mocked the analysts for underestimating Mercer. Still others took the opportunity to argue about general topics that had nothing to do with prosthetics. The familiar pattern of online discourse, applied to a new set of stimuli.
In all of this, the unintended beneficiary was Prism Sciences.
Ryan had managed to talk Patricia out of intervening. She'd offered to coordinate a counter-narrative through Aegis-friendly outlets, and Ryan had declined. The reason was strategic: this round of attention wasn't focused on him personally. It was focused on Prism Sciences. And Prism Sciences badly needed the international name recognition.
Tom, watching the coverage from his office, was downright joyful.
Before Helios's campaign launched, Prism Sciences' international name recognition had been minimal. The company existed in a few specialized industry databases and had received occasional mention in coverage of Ryan's projects. Now, in a matter of days, Prism Sciences had become a globally recognized brand. The name was appearing in every major business publication. Every analyst on every continent had an opinion about it. Every investor was now familiar with the company that had dared to challenge Helios.
Helios had spent millions of dollars to give Prism Sciences exactly the brand exposure that would normally have required years and a comparable budget to achieve organically.
If Tom had tried to buy this level of international visibility through conventional advertising, the cost would have been staggering. Television campaigns in twenty markets. Sponsored content placements. Trade publication advertorials. Conference appearances. Public relations retainers. Tens of millions of dollars, easily, and even then the results would have been incremental.
Helios had handed it to him for free.
He smiled at his monitor, raised his coffee mug in a private toast to Michael Reeve, and went back to reviewing the manufacturing schedules.
Forty-five days to launch.
The fish was in the net. Now he had to make sure the product worked.
-----